Study of MRx0518 and Avelumab in Patients With Urothelial Carcinoma
Clinical trial NCT05107427 · WITHDRAWN
Trial details
- NCT number
- NCT05107427
- Sponsor
- 4D pharma plc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.